Skip to content

King Pharmaceuticals KG Workers' Compensation — Year 5

Other product segments

Commercial Auto Liability
14%
General Liability
14%
European Hospital Liability
11.9%
All other lines
3.6%
International
-0.8%

Similar metrics at other companies

CNA Financial logo
CNAWorkers' Compensation — Year 5
5.8%-0.1pp
Old Republic International logo
ORIWorkers' Compensation — Year 5
5.1%-0.1pp
United Fire Group logo
UFCSCommercial workers' compensation — Year 5
4.1%+0.1pp
The Hartford Financial Services Group logo
HIGWorkers' Compensation — 5th Year
5.8%+0.1pp
CNA Financial logo
CNAWorkers' Compensation — Year 6
3.8%0.0pp
PRA
PRAWorkers' Compensation Insurance — Historical claims duration, year 5 (percent)
2.3%0.0pp

Other financials

Income statement

See full
Revenue$10.2M+1,112%
Net income-$7.4M-1,786%
EPS (diluted)-$0.96-586%

Balance sheet

See full
Cash & equivalents$62.2M+1,724%
Total debt$176.7M
Total equity$121.4M+2,773%
Total assets$964.2M

Cash flow

See full
Operating cash flow-$15.1M-1,628%

Valuation

See full
Market cap$70.42M-67.6%
Enterprise value$184.93M-50.0%
P/E1.2×
P/S1.6×-24.3×

Profitability

See full
Net margin131.5%

Returns & leverage

See full
Return on equity90.8%
Debt / equity1.5×

Where this comes from

Reported directly by King Pharmaceuticals in its filing.

Tagged under the XBRL concept us-gaap:ShortdurationInsuranceContractsHistoricalClaimsDurationYearFive.

The official record: King Pharmaceuticals’s 10-K, filed March 13, 2026, on SEC EDGAR. View the filing →

Ask your AI about King Pharmaceuticals's workers' compensation — year 5.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is King Pharmaceuticals's workers' compensation — year 5?
King Pharmaceuticals (KG) reported workers' compensation — year 5 of 5% in Q4 2025.
What does workers' compensation — year 5 mean?
This metric tracks the financial contribution of the Workers' Compensation insurance segment in the fifth year of operations. It serves as a key indicator of market penetration and product demand for employer-mandated injury coverage.